Last reviewed · How we verify
Partial seizure
Approved treatments
- Xcopri · SK Life Science, Inc.
- Aptiom · Sumitomo Pharma Am
Aptiom works by blocking sodium channels in the brain to reduce the frequency of seizures. - Briviact · UCB
Briviact works by binding to the synaptic vesicle glycoprotein 2A, reducing the release of neurotransmitters and stabilizing neuronal activity. - Fycompa · Catalyst Pharms
Fycompa works by blocking the AMPA glutamate receptor, which is involved in the transmission of nerve impulses. - Xcopri · Sk Life
Xcopri works by enhancing the activity of a neurotransmitter called GABA, which helps calm down abnormal electrical activity in the brain. - Zebinix · Centre Hospitalier Saint Joseph Saint Luc de Lyon
- Fycompa · Eisai Inc.
Clinical guidelines
- FDA label — any
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Partial seizure patent landscape — cliff calendar, originator estates, attackable patents
- Partial seizure treatment landscape brief
- Partial seizure treatment updates RSS
Frequently asked questions about Partial seizure
What drugs treat Partial seizure?
Tracked treatments include Xcopri, Aptiom, Briviact, Fycompa, Zebinix.
What is the treatment for Partial seizure?
Standard treatment for Partial seizure includes Xcopri, Aptiom, Briviact, Fycompa, Zebinix. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Partial seizure?
FDA label publishes guidelines for Partial seizure. 1 guideline references tracked.
Related
- Treatment landscape: Partial seizure patent cliff · Partial seizure CI report
- Treatment: Xcopri · SK Life Science, Inc.
- Treatment: Aptiom · Sumitomo Pharma Am
- Treatment: Briviact · UCB
- Treatment: Fycompa · Catalyst Pharms
- Treatment: Xcopri · Sk Life
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing